Extent of Resection Versus Molecular Classification: What Matters When?
Sign Up to like & getrecommendations! Published in 2019 at "Neurosurgery clinics of North America"
DOI: 10.1016/j.nec.2018.08.006
Abstract: For malignant gliomas, the survival benefit of new combination therapies after surgical resection is measured in weeks to months. In contrast, optimizing treatment for low-grade gliomas can potentially provide additional years of life. The relatively… read more here.
Keywords: molecular classification; extent resection; versus molecular; resection versus ... See more keywords
Resection versus biopsy in patients with glioblastoma (RESBIOP study): study protocol for an international multicentre prospective cohort study (ENCRAM 2202)
Sign Up to like & getrecommendations! Published in 2024 at "BMJ Open"
DOI: 10.1136/bmjopen-2023-081689
Abstract: Introduction There are no guidelines or prospective studies defining the optimal surgical treatment for glioblastomas in older patients (≥70 years), for those with a limited functioning performance at presentation (Karnofsky Performance Scale ≤70) or for… read more here.
Keywords: resection versus; resection; biopsy; multicentre prospective ... See more keywords